Sage Journals: Discover world-class research

Retricted access

Research article

First published 2000-10

Multiple sclerosis,disease modifying treatments and depression: a critical methodological review

Anthony Feinstein

Multiple Sclerosis Journal

Open access

Review article

First published 2024

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

Celia Oreja-Guevara, Sergio Martínez-Yélamos, Sara Eichau [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2024-4

Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study

Soeren Mattke, Yu Tang, Mark Hanson

Journal of Health Services Research & Policy

Open access

Review article

First published 2024

Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China

Jun Guo, Jiayong Wu, Lihua Wang [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2023-12

Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis

Sarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2011-7

Disease-modifying treatments for Alzheimer’s disease

Daniela Galimberti, Elio Scarpini

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018-4

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies

Mark S Freedman, Jerry S Wolinsky, Giancarlo Comi [...]

Multiple Sclerosis Journal

Retricted access

Editorial

First published 2025-8

Donanemab: The dawn of disease-modifying treatment for Alzheimer’s disease in Australia

Samantha M Loi, Matthew JY Kang

Australasian Psychiatry

Retricted access

Research article

First published 2022-12

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations

Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Treatment access and satisfaction on disease-modifying therapies of neuromyelitis optica spectrum disorder patients in China: a cross-sectional survey

Yue Yu, Mingkang Zhong, Chao Quan [...]

Therapeutic Advances in Neurological Disorders

Search results